WHO ICTRP trial
Clinical application study of albumin-bilirubin grading in predicting the…
ChiCTR2500103074 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500103074 |
|---|---|
| Public title | Clinical application study of albumin-bilirubin grading in predicting the perioperative risk of radical resection of hepatic portal bile duct cancer |
| Scientific title | Clinical application study of albumin-bilirubin grading in predicting the perioperative risk of radical resection of hepatic portal bile duct cancer |
| Primary sponsor | The First Affiliated Hospital of Army Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Hilar cholangiocarcinoma |
| Interventions | ALBI Level 1:NA;ALBI Level 2:NA;ALBI Level 3:NA |
| Registration date | May 23, 2025 |
| Target size | ALBI Level 1:100;ALBI Level 2:100;ALBI Level 3:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: